Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options.
about
Diabetic neuropathic pain: Physiopathology and treatmentProtein carbonylation, cellular dysfunction, and disease progressionImmunohistochemical study of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 in the hippocampal vasculature: pathological synergy of Alzheimer's disease and diabetes mellitusNutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetesSystemic activation of NF-κB driven luciferase activity in transgenic mice fed advanced glycation end products modified albumin.Immunohistochemical study of N-epsilon-carboxymethyl lysine (CML) in human brain: relation to vascular dementia.Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatmentThe fusion of bone-marrow-derived proinsulin-expressing cells with nerve cells underlies diabetic neuropathy.Chronic diabetic complications: the body's adaptive response to hyperglycemia gone awry?Bone marrow-derived TNF-α causes diabetic neuropathy in mice.Impaired neurovascular repair in subjects with diabetes following experimental intracutaneous axotomyInactivation of TNF-α ameliorates diabetic neuropathy in mice.Comparison of oxidant/antioxidant, detoxification systems in various tissue homogenates and mitochondria of rats with diabetes induced by streptozocin.Aqueous humor outflow: what do we know? Where will it lead us?Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.Pathogenesis of diabetic neuropathy: bad to the bone.High Glucose-Induced PC12 Cell Death by Increasing Glutamate Production and Decreasing Methyl Group Metabolism.Ablation of a small subpopulation of diabetes-specific bone marrow-derived cells in mice protects against diabetic neuropathy.Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes.Abnormal calcium homeostasis in peripheral neuropathies.Advanced glycation endproducts and their pathogenic roles in neurological disorders.Electrical spinal cord stimulation in painful diabetic polyneuropathy, a systematic review on treatment efficacy and safety.Anti-inflammatory therapy for diabetic retinopathy.Inflammation and diabetic retinal microvascular complications.Contemporary insights into painful diabetic neuropathy and treatment with spinal cord stimulation.The diverse ligand repertoire of the receptor for advanced glycation endproducts and pathways to the complications of diabetes.Current therapeutic interventions in the glycation pathway: evidence from clinical studies.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Mechanism of diabetic neuropathy: Where are we now and where to go?Diabetes-induced mechanophysiological changes in the small intestine and colon.Transcriptional activation of the aldehyde reductase YqhD by YqhC and its implication in glyoxal metabolism of Escherichia coli K-12.Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy.RAGE mediates the inactivation of nAChRs in sympathetic neurons under high glucose conditions.The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic PMetabolic links between diabetes and Alzheimer's disease.Pepino polyphenolic extract improved oxidative, inflammatory and glycative stress in the sciatic nerves of diabetic mice.Potential inplications of endogenous aldehydes in beta-amyloid misfolding, oligomerization and fibrillogenesis.
P2860
Q27004604-DD24E206-7841-4D3C-AF86-B36B910577CAQ28248107-AE7BC42D-9A54-4799-BBD6-A63C1F09BBCCQ28269188-A431429B-4E80-44B0-AB28-D85EAEDEA3A0Q28385506-9BD23B99-F500-451C-8C1D-89601795A7C1Q30313434-F0F9CE12-4F0E-478E-8EF1-325E81E71A92Q33302856-9E1B83B8-F865-49A0-830A-DB761BEA1197Q33750650-219EDC6A-5EE7-4A83-9191-8526DB6C7A8FQ33933972-E5C88EDF-B2EF-4BC8-919B-7B6A261CB3AEQ34767192-6DA157BE-414C-4C63-8DFD-C43C840CD1E4Q34899309-608252EA-82D2-4892-A78D-7C84195C2F88Q35119787-4B138E86-6E41-45DD-8126-AA9AB433DED2Q35543628-A1408C94-4D05-46E9-923D-C31AD64B6FA9Q35872225-93A07F5E-A189-4C4C-9FFB-6030AAB0C170Q36166251-BE0C26D1-B76E-4CCA-8B77-B1B362EBE311Q36384149-36B5F93A-F365-464D-913A-E395A9D5C43AQ36426843-07ADCE23-4C7D-488A-8FF4-9F8717A231AFQ36431827-1F1AD6C8-2138-4B62-8860-4885567FD27DQ36796321-B73579E3-819B-4AE8-94FE-F6A76232393CQ37060029-6FA3E33A-7388-4E1B-BA24-8CAEA2E8EC30Q37148729-91C3E968-8097-4124-AEAA-8AA63F009525Q37373683-71C1504E-6257-4DE8-AC87-7D6678D51E78Q37429192-992A17AE-41A6-4F4A-9F93-58D01151191CQ37662579-353F26EE-49AD-4286-AFEA-3889312A89C9Q37800424-BC265215-6A87-41A8-A7F8-D29BE703935AQ37846329-3354B762-F4D9-4AF1-A923-53342F79B51DQ37873482-128C3DF2-A717-4040-BFF8-B622E1D9509DQ37911285-9442EE72-9039-4B8B-B428-BF074287769EQ37954530-B32213DF-3F70-4247-B71E-3CF3C3BAAA09Q38023062-C53EE4F5-6258-4416-92C6-061195E59C62Q38070906-6092AB85-CC98-4649-A7DB-EED21A774AA7Q38096444-E1D5974C-2EBD-47CE-95CA-DE633D37AC0FQ38213041-90453A72-273F-419B-9D4F-778386579D02Q39427195-775BAACA-4292-4DDD-8CB1-D6BE6A20DAAAQ42576196-D23F4A6C-55CD-47BD-BAB3-FCB4A23A1407Q42583958-7C4CF7CC-A426-46C6-847C-7ACDDE400B07Q43935666-410F395A-8CF7-40C6-89E8-D3869574227CQ44648415-49AAB199-3F77-4D9E-A40F-33DC4221FA29Q46032053-CDDD79C9-E24A-4866-92D9-5789BD2D239FQ46607613-14AA3A10-86DA-435F-AD42-4C14B47957D0Q48383092-9BF13981-031A-4D5A-8CA8-3987406F65B7
P2860
Glycation in diabetic neuropathy: characteristics, consequences, causes, and therapeutic options.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@ast
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@en
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@nl
type
label
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@ast
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@en
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@nl
prefLabel
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@ast
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@en
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@nl
P1476
Glycation in diabetic neuropat ...... uses, and therapeutic options.
@en
P2093
Paul J Thornalley
P356
10.1016/S0074-7742(02)50072-6
P577
2002-01-01T00:00:00Z